March 23, 2018
Sandoz receives positive CHMP opinion for proposed biosimilar infliximab
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 23, 2018
Novartis to seek approval for first SPMS (multiple sclerosis) therapy after the positive Phase III results
Novartis could have the first therapy which could delay disability progression secondary progressive multiple sclerosis (SPMS) if it gets the…
March 23, 2018
GSK’s shingles prevention vaccine approved in Europe and Japan
GlaxoSmithKline got the approval for shingles prevention, and post-herpetic neuralgia (PHN) vaccine Shingrix, in Europe, while in Japan it was registered…
March 23, 2018
Novo Nordisk’s type two diabetes treatment for adults approved in japan
The Japanese Ministry of Health, Labour and Welfare has approved Novo Nordisk’s treatment for type 2 diabetes adult patients, new…
March 22, 2018
First Japanese company joins CARB-X partnership in the fight against drug resistant bacteria
CARB-X is partnering with Shionogi of Osaka, Japan, to support the development of a novel β-lactam antibiotic with potent activity…
March 21, 2018
FDA: 5 Things to Know About Breast Implants
Should I get breast implants? Are there alternatives? Will they need to be replaced? And if I decide to get…
March 21, 2018
Sobi launches Ravicti in Europe and advances the care for patients with Urea Cycle Disorders
Swedish Orphan Biovitrum has gained reimbursement for Ravicti, a new therapy option for the treatment of patients with Urea Cycle…
March 20, 2018
Fifth FDA-approved indication for Adcetris changes four decades old way to treat Hodgkin lymphoma
The U.S. Food and Drug Administration on Tuesday approved Saettle Genetics’s Adcetris (brentuximab vedotin) to treat adult patients with previously…
March 20, 2018
Mylan launches Mitomycin, generic cancer drug version of BMS’s Mutamycin
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…
March 20, 2018
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
Novartis has teamed up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber…